{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:11:06Z","timestamp":1788779466087,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.resmer.2025.101171","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T23:13:17Z","timestamp":1744758797000},"page":"101171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of inhaled corticosteroids on metabolic dysfunction-associated steatotic liver disease risk in COPD patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Jiyu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deog Kyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-0260","authenticated-orcid":false,"given":"Hyun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.resmer.2025.101171_bib0001","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.resmer.2025.101171_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002958","article-title":"Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: systematic review and bayesian network meta-analysis","volume":"16","author":"Lee","year":"2019","journal-title":"PLoS Med."},{"issue":"10","key":"10.1016\/j.resmer.2025.101171_bib0004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1164\/rccm.202102-0289OC","article-title":"Effects of inhaled corticosteroid\/long-acting \u03b2(2)-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM)","volume":"204","author":"Leitao Filho","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.resmer.2025.101171_bib0005","article-title":"Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease","volume":"3","author":"Yang","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.resmer.2025.101171_bib0006","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a systematic review and meta-analysis of randomized controlled trials. A systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0007","article-title":"Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.resmer.2025.101171_bib0008","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.resmer.2025.101171_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/14740338.2015.1001363","article-title":"Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease","volume":"14","author":"Matera","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"160","key":"10.1016\/j.resmer.2025.101171_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0075-2021","article-title":"Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD","volume":"30","author":"Miravitlles","year":"2021","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"issue":"4","key":"10.1016\/j.resmer.2025.101171_bib0011","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.resmer.2025.101171_bib0012","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.resmer.2025.101171_bib0013","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.resmer.2025.101171_bib0014","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.resmer.2025.101171_bib0015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes, metabolic syndrome and obesity: targets and therapy"},{"issue":"10","key":"10.1016\/j.resmer.2025.101171_bib0016","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.resmer.2025.101171_bib0017","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12931-021-01684-1","article-title":"Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease","volume":"22","author":"Park","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.resmer.2025.101171_bib0019","first-page":"561","article-title":"The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data","volume":"8","author":"Kim","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.resmer.2025.101171_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162903","article-title":"Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study","volume":"11","author":"Price","year":"2016","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1183\/09031936.99.141","article-title":"Deteriorating diabetic control associated with high-dose inhaled budesonide","volume":"14","author":"Faul","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.resmer.2025.101171_bib0023","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.resmer.2025.101171_bib0024","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/ijms22020623","article-title":"Molecular mechanisms of glucocorticoid-induced insulin resistance","volume":"22","author":"Beaupere","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resmer.2025.101171_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diabres.2018.03.006","article-title":"Steroid-induced hyperglycemia: an underdiagnosed problem or clinical inertia? A narrative review","volume":"139","author":"Bonaventura","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.resmer.2025.101171_bib0026","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1262-3636(07)70123-4","article-title":"Dexamethasone-induced insulin resistance shows no gender difference in healthy humans","volume":"30","author":"Binnert","year":"2004","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.resmer.2025.101171_bib0027","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.resmer.2025.101171_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4046\/trd.2021.0179","article-title":"Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review","volume":"85","author":"Santos","year":"2022","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"5","key":"10.1016\/j.resmer.2025.101171_bib0029","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2500\/aap.2022.43.220027","article-title":"Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma","volume":"43","author":"Wangberg","year":"2022","journal-title":"Allergy and asthma proceedings"},{"key":"10.1016\/j.resmer.2025.101171_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874306401408010101","article-title":"Effect of inhaled corticosteroids on glycemic status","volume":"8","author":"Egbuonu","year":"2014","journal-title":"Open Respir Med J"},{"issue":"5","key":"10.1016\/j.resmer.2025.101171_bib0031","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/biomedicines10051110","article-title":"Inhaled corticosteroids selectively alter the microbiome and host transcriptome in the small airways of patients with chronic obstructive pulmonary disease","volume":"10","author":"Yip","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.resmer.2025.101171_bib0032","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.dld.2016.03.022","article-title":"Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts","volume":"48","author":"Xiao","year":"2016","journal-title":"Dig Liver dis"},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0033","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.resmer.2025.101171_bib0034","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary","year":"2021","journal-title":"Translational gastroenterology and hepatology"},{"issue":"1","key":"10.1016\/j.resmer.2025.101171_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1183\/09031936.00080912","article-title":"The use of inhaled corticosteroids and the risk of adrenal insufficiency","volume":"42","author":"Lapi","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.resmer.2025.101171_bib0036","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.rmed.2005.11.020","article-title":"Systemic side effects of inhaled corticosteroids in patients with asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101171_bib0037","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2147\/COPD.S172240","article-title":"Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.resmer.2025.101171_bib0038","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.0306-5251.2001.01493.x","article-title":"Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler","volume":"52","author":"Thorsson","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.resmer.2025.101171_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874306401408010059","article-title":"Systemic effects of inhaled corticosteroids: an overview","volume":"8","author":"Pandya","year":"2014","journal-title":"Open Respir Med J"},{"issue":"9","key":"10.1016\/j.resmer.2025.101171_bib0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.resmer.2025.101171_bib0041","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.resmer.2025.101171_bib0042","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/liv.14626","article-title":"Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:34:42Z","timestamp":1748518482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":42,"alternative-id":["S2590041225000182"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101171","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of inhaled corticosteroids on metabolic dysfunction-associated steatotic liver disease risk in COPD patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101171"}}